FIELD: medicine.
SUBSTANCE: define at the patient content of interferon-γ (INF-γ) in blood serum prior to the beginning of treatment and in 2 weeks after the beginning. Prognosticate stable remission, if in 2 weeks after the beginning of treatment the content of INF-γ in 1.5-2 times and more exceeds the content of INF-γ prior to the beginning of treatment.
EFFECT: increase of accuracy of stable remission predicting at early stages of disease that gives the chance of timely correction of antiviral therapy tactics.
2 ex, 3 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTION OF ANTIVIRAL THERAPY (AVT) EFFICACY IN CHRONIC HEPATITIS B (CHB) | 2011 |
|
RU2454666C1 |
| METHOD FOR PREDICTION OF STABLE VIROLOGICAL RESPONSE TO ANTI-VIRAL THERAPY OF CHRONIC VIRAL HEPATITIS C ACCOMPANYING HIV INFECTION | 2013 |
|
RU2558793C2 |
| METHOD FOR PREDICTING ACUTE HEPATITIS C OUTCOME | 2006 |
|
RU2317552C1 |
| METHOD FOR PREDICTING THE RESULT OF ACUTE HEPATITIS C | 2004 |
|
RU2261662C1 |
| METHOD FOR PREDICTING THE RESULTS OF TREATING PATIENTS WITH CHRONIC HEPATITIS C WITH INTERFERON-ALPHA PREPARATIONS | 2005 |
|
RU2287825C1 |
| METHOD FOR PREDICTING EFFICIENCY OF INTERFERONOTHERAPY AT CHRONIC HEPATITIS B | 2005 |
|
RU2287826C1 |
| METHOD OF TREATING PATIENTS WITH CHRONIC VIRAL HEPATITIS TYPE C, GENOTYPE 3a | 2009 |
|
RU2400229C1 |
| METHOD FOR PREDICTION OF EFFICACY OF ANTIVIRAL THERAPY IN ADULT PATIENTS WITH CHRONIC HEPATITIS C GENOTYPE 1b | 2012 |
|
RU2522500C1 |
| METHOD FOR PREDICTION OF FORMATION OF VIROLOGICAL RESPONSE IN PATIENTS WITH CHRONIC HEPATITIS C | 2011 |
|
RU2461834C1 |
| METHOD FOR PREDICTING ANTIVIRAL TREATMENT RESPONSE IN CHRONIC HEPATITIS C | 2013 |
|
RU2557534C2 |
